Cannabidiol and its potential evidence-based psychiatric benefits–a critical review
The endocannabinoid system shows promise as a novel target for treating psychiatric
conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in …
conditions. Cannabidiol (CBD), a naturally occurring cannabinoid, has been investigated in …
Left hemisphere lateralization of the limbic system and frontoparietal network (FPN) correlates with positive and negative symptom improvement following cannabidiol …
ZP Pierce, AS Bogatz, ER Johnson, BE Lear… - Journal of Psychiatric …, 2024 - Elsevier
This voxel-wise meta-analysis assesses current findings about the neural correlates of
cannabidiol on the positive and negative symptoms among individuals with psychosis or …
cannabidiol on the positive and negative symptoms among individuals with psychosis or …
Differential effects of cannabis constituents on schizophrenia-related psychosis: a rationale for incorporating cannabidiol into a schizophrenia therapeutic regimen
K Johnson, AJ Weldon, MA Burmeister - Frontiers in Psychiatry, 2024 - frontiersin.org
Schizophrenia is a serious mental health disorder that confers one of the highest mortality
rates of all psychiatric illnesses. Although the disorder's psychotic symptoms are treatable …
rates of all psychiatric illnesses. Although the disorder's psychotic symptoms are treatable …